Medical News Today: Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 2, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news
Deep brain stimulation in a rat model of post-traumatic stress disorder modifies forebrain neuronal activity and serum corticosterone - Hashtjini MM, Jahromi GP, Sadr SS, Meftahi GH, Hatef B, Javidnazar D.
OBJECTIVES: Post-traumatic stress disorder (PTSD), one of the most devastating kinds of anxiety disorders, is the consequence of a traumatic event followed by intense fear. In rats with contextual fear conditioning (CFC), a model of PTSD caused by CFC (ele... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Self-tuning brain implant could help treat patients with Parkinson ’s disease
NIH BRAIN Initiative-funded research a key first step to improving deep brain stimulation. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 29, 2018 Category: American Health Source Type: news
Self-tuning brain implant could help treat patients with Parkinson's disease
This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signaling. The study was supported by the National Institutes of Health's Brain Research through Advancing Innovative Technologies (BRAIN) Initiative and the National Institute of Neurological Disorders and Stroke (NINDS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2018 Category: International Medicine & Public Health Source Type: news
Deep brain stimulation may offer treatment for type 2 diabetes, study suggests
A surprising (but welcome) side effect of a therapy for obsessive-compulsive disorder may pave the way for a new approach to treating type 2 diabetes — and offer new insights into the links between obesity and the metabolic disease that afflicts close to 1 in 10 American adults.The therapy in... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 26, 2018 Category: Science Authors: Melissa Healy Source Type: news
Neuromodulation Continues to be Activity Hotbed
The Neuromodulation market is rapidly growing and has become host to many medtech companies. StimGuard is the latest firm to make significant moves in the space, as it has received CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder.
The Pompano Beach, Fla.-based company said its StimGuard would be available in Europe in the summer of 2018.
“A wireless system that enables urologists to inject such a clinically proven therapy represents a shift in the field where there has only been one option for over 15 years,” Karl-Dietrich Sievert MD, PhD, professor and co-chairman of urolog...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news
As a Buddhist Priest, Duke Neurosurgeon Finds Deeper Connection with Patients
Treatment TermsNeurosurgery
Author
Bryan Roth
Overview
Dr. Patrick Codd, MD, a Duke neurosurgeon, has been practicing Zen for two decades. The practice, he says, allows him to reflect on his work and relationships with patients and, ultimately, to deliver better care.
Content Blocks
Preview Image
Featured Doctors and Providers
Patrick J. Codd, MD
Related Blog Posts
5 Minutes with Duke Neurosurgeon Oren Gottfried, MD
Robot Reduces Need for Open Brain Surgery to Map Epileptic Seizures
Deep brain stimulation surgery while asleep brings relief from dystonia
BodyDisplay in Announcement Section:
...
Source: dukehealth.org: Duke Health News - May 16, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news
INTREPID: New DBS System for Parkinson's Meets Endpoints INTREPID: New DBS System for Parkinson's Meets Endpoints
A new multiple-source system for deep-brain stimulation in patients with Parkinson ' s disease proved effective in the randomized, double-blind INTREPID trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Deep Brain Stimulation Affects the Activity of Hundreds of Genes
Changes in gene activity levels after DBS appear to underlie improvements seen in a mouse model of Rett syndrome, a genetic disease that causes intellectual disability. (Source: The Scientist)
Source: The Scientist - May 14, 2018 Category: Science Tags: Daily News,The Scientist Source Type: news
Report: Doctors warn that lightning can affect deep brain stimulation devices
Deep brain stimulation devices, used to treat neurological movement disorders like Parkinson’s disease, are vulnerable to strong electromagnetic fields that are created by other electrical devices.
But when a 66-year-old Slovenian woman’s DBS implant stopped working, it wasn’t due to interference from a device – the malfunction was caused by lightning.
In a case report published this week in the Journal of Neurosurgery, doctors described a unique case they encountered with a patient using a rechargeable DBS system to treat her neck dystonia. When her apartment was struck by lightning, the patient&#...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Neurological Source Type: news
Lightning Can Affect Deep Brain Stimulation Devices
THURSDAY, May 3, 2018 -- Lightning, which can result in strong electromagnetic fields (EMFs), can interfere with deep brain stimulation (DBS) devices, according to a case report published online May 1 in the Journal of Neurosurgery.
Noting that DBS... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2018 Category: Pharmaceuticals Source Type: news
FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy
The FDA has granted premarket approval for Medtronic ' s deep-brain stimulation therapy as adjunctive treatment for seizure reduction in adults with refractory epilepsy, the company announced.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news
Medtronic wins FDA PMA for DBS epilepsy treatment
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its Deep Brain Stimulation therapy, indicated as an adjunctive treatment for reducing the frequency of partial-onset seizures.
The DBS treatment is cleared for patients 18 years or older who are refractory or drug resistant to three or more antiepileptic medications, the Fridley, Minn.-based company said.
Medtronic’s DBS therapy functions through the delivery of controlled electrical pulses to the anterior nucleus of the thalamus which is part of a network involved in seizures, the company said.
Approval came based on seven years of data from the comp...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Pre-Market Approval (PMA) Regulatory/Compliance Medtronic Source Type: news
Lightning carries potential danger to people with deep brain stimulators
(Journal of Neurosurgery Publishing Group) Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields generated by particular electrical devices found at work, home, and in the hospital. A new and potentially dangerous source of dysfunction has been identified: nearby lightening. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 1, 2018 Category: Biology Source Type: news
